GI Innovation, Inc. (358570.KQ)

KRW 14540.0

(0.62%)

Total Debt Summary of GI Innovation, Inc.

GI Innovation, Inc.'s latest annual total debt in 2023 was 3.72 Billion KRW , down -12.93% from previous year.
GI Innovation, Inc.'s latest quarterly total debt in 2024 Q2 was 3.64 Billion KRW , up 0.19% from previous quarter.
GI Innovation, Inc. reported annual total debt of 4.27 Billion KRW in 2022, down -2.0% from previous year.
GI Innovation, Inc. reported annual total debt of 4.36 Billion KRW in 2021, down -97.42% from previous year.
GI Innovation, Inc. reported quarterly total debt of 3.63 Billion KRW for 2024 Q1, down -2.33% from previous quarter.
GI Innovation, Inc. reported quarterly total debt of 3.72 Billion KRW for 2023 FY, down -12.93% from previous quarter.

Annual Total Debt Chart of GI Innovation, Inc. (2023 - 2019)

Historical Annual Total Debt of GI Innovation, Inc. (2023 - 2019)

Year	Total Debt	Total Debt Growth
2023	3.72 Billion KRW	-12.93%
2022	4.27 Billion KRW	-2.0%
2021	4.36 Billion KRW	-97.42%
2020	168.75 Billion KRW	49.66%
2019	112.75 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	3.64 Billion KRW	0.19%
2024 Q1	3.63 Billion KRW	-2.33%
2023 FY	3.72 Billion KRW	-12.93%
2023 Q4	3.72 Billion KRW	-3.44%
2023 Q3	3.85 Billion KRW	-1.01%
2023 Q2	3.89 Billion KRW	-6.9%
2023 Q1	4.18 Billion KRW	-2.15%
2022 Q2	4.19 Billion KRW	-2.16%
2022 Q1	4.28 Billion KRW	-1.76%
2022 Q3	4.24 Billion KRW	1.32%
2022 Q4	4.27 Billion KRW	0.63%
2021 Q3	3.99 Billion KRW	0.0%
2021 Q4	4.36 Billion KRW	9.09%

Peer Total Debt Comparison of GI Innovation, Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	94.066%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-823.491%
BINEX Co., Ltd.	53.5 Billion KRW	93.046%
Bioneer Corporation	44.63 Billion KRW	91.665%
Anterogen.Co.,Ltd.	9.74 Billion KRW	61.8%
MEDIPOST Co., Ltd.	52.33 Billion KRW	92.891%
CrystalGenomics, Inc.	32 Billion USD	88.374%
Helixmith Co., Ltd	20.22 Billion KRW	81.605%
Chabiotech Co.,Ltd.	449.63 Billion KRW	99.172%
Medy-Tox Inc.	82.83 Billion KRW	95.508%
Peptron, Inc.	9.13 Billion KRW	59.259%
Amicogen, Inc.	149.59 Billion KRW	97.513%
Genexine, Inc.	67.42 Billion KRW	94.482%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	62.875%
LegoChem Biosciences, Inc.	12.64 Billion KRW	70.572%
ALTEOGEN Inc.	83.76 Billion KRW	95.558%
PharmaResearch Co., Ltd.	34.3 Billion KRW	89.154%
SillaJen, Inc.	9.69 Billion KRW	61.628%
JETEMA, Co., Ltd.	130.49 Billion KRW	97.149%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	90.546%
Genomictree Inc.	1.83 Billion KRW	-102.808%
MedPacto, Inc.	8.6 Billion KRW	56.755%
D&D Pharmatech	8.13 Billion KRW	54.258%
EASY BIO,Inc.	82.27 Billion KRW	95.478%